Leukemia,%20Lymphocytic,%20Chronic,%20B-Cell
Showing 9951 - 9975 of >10,000
Childhood Acute Lymphoblastic Leukaemia: Follow-Up
Completed
- Precursor Cell Lymphoblastic Leukemia-Lymphoma
- Recurrence
- Mode of relapse/SMN detection
-
Aarhus N, Denmark
- +4 more
Aug 31, 2021
Hepatocellular Carcinoma Trial (IPM001)
Not yet recruiting
- Hepatocellular Carcinoma
- IPM001
- (no location specified)
Sep 7, 2022
Sperm DNA Fragmentation, Infertility Trial in Cairo (PICSI, MACS, Microfluidics)
Recruiting
- Sperm DNA Fragmentation
- Infertility
- PICSI
- +2 more
-
Cairo, Maadi, EgyptGanin Fertility Center
Aug 11, 2022
Cystic Fibrosis in Children Trial in Liverpool (PlayPhysio)
Recruiting
- Cystic Fibrosis in Children
- PlayPhysio
-
Liverpool, Merseyside, United KingdomAlder Hey Children's NHS Foundation Trust
Aug 11, 2022
Eliminating HCV Infection Among PWUD
Recruiting
- Hepatitis C, Chronic
- Drug Use
-
Vancouver, British Columbia, CanadaVancouver Infectious Diseases Centre
Jul 22, 2022
Breath Metabolomics in the Laboring Parturient
Suspended
- Labor Onset and Length Abnormalities
- Breath Sample
-
Stanford, CaliforniaLucile Packard Children Hospital
Oct 18, 2022
Lung Transplant Failure, Lung Transplant; Complications Trial in Lund (CytoSorb)
Recruiting
- Lung Transplant Failure
- Lung Transplant; Complications
- CytoSorb
-
Lund, Skåne Län, SwedenSkåne University Hospital
Feb 6, 2022
Protease Inhibitors in Chronic Hepatitis C
Completed
- Chronic Hepatitis C
-
Graz, AustriaDepartment of Internal Medicine, Medical University of Graz
Jan 11, 2023
Peripheral T-cell Lymphoma Trial in Tianjin (Lposomal mitoxantrone HCl,Cyclophosphamide,Vincristine,Etoposide and
Not yet recruiting
- Peripheral T-cell Lymphoma
- Lposomal mitoxantrone hydrochloride,Cyclophosphamide,Vincristine,Etoposide and Prednisone(CMOEP)
-
Tianjin, Tianjin, ChinaTianjin Medical University Cancer Insititute & Hospital
Jul 13, 2022
Chronic Myelogenous Leukemia Trial in Boston (Arsenic trioxide)
Terminated
- Chronic Myelogenous Leukemia
- Arsenic trioxide
-
Boston, MassachusettsBeth Israel Deaconess Medical Center
Sep 4, 2018
NSCLC, Carcinoma Breast Trial in Suzhou (Vinorelbine, Radiotherapy, PD-1/PD-L1 inhibitor)
Not yet recruiting
- Carcinoma, Non-Small-Cell Lung
- Carcinoma Breast
- Vinorelbine
- +4 more
-
Suzhou, ChinaSecond Affiliated Hospital of Soochow University
Oct 29, 2022
NSCLC Trial in Philadelphia (Pembrolizumab)
Active, not recruiting
- Non-small Cell Lung Cancer
-
Philadelphia, PennsylvaniaAbramson Cancer Center of the University of Pennsylvania
Nov 1, 2022
Clinical Relevance of Intracellular Staphylococci in BOne and
Completed
- Bone and Joint Infection
- Staphylococcus
- Patients having had an osteo-articular infection with Stahylococcus
-
Lyon, FranceHospices Civils de Lyon
Jan 11, 2022
Cerebral Adrenoleukodystrophy (CALD) Trial in Worldwide (Lenti-D Drug Product (eli-cel))
Completed
- Cerebral Adrenoleukodystrophy (CALD)
- Lenti-D Drug Product (eli-cel)
-
Los Angeles, California
- +7 more
Mar 25, 2022
Metachromatic Leukodystrophy, Adrenoleukodystrophy Trial in Shenzhen (transduced CD34+ hematopoietic stem cell)
Recruiting
- Metachromatic Leukodystrophy
- Adrenoleukodystrophy
- transduced CD34+ hematopoietic stem cell
-
Shenzhen, Guangdong, ChinaShenzhen Second People's Hospital, The First Affiliated Hospital
May 25, 2022
Otitis Media Chronic, Temporal Bone Trial in Ljubljana (Platelet- and extracellular vesicle-rich plasma, Standard conservative
Completed
- Otitis Media Chronic
- Temporal Bone
- Platelet- and extracellular vesicle-rich plasma
- Standard conservative treatment
-
Ljubljana, SloveniaUniversity Medical Centre Ljubljana
Aug 2, 2021
Acute Myeloid Leukemia, Measurable Disease Trial in Tianjin (Venetoclax, Azacitidine, Venetoclax, daunorubicin, cytarabine)
Recruiting
- Acute Myeloid Leukemia
- Measurable Disease
- Venetoclax, Azacitidine
- Venetoclax, daunorubicin, cytarabine
-
Tianjin, Tianjin, ChinaHBDH
Apr 28, 2022
Duchenne Muscular Dystrophy Trial in Columbus (SRP-9001)
Active, not recruiting
- Duchenne Muscular Dystrophy
- SRP-9001
-
Columbus, OhioNationwide Children's Hospital
Jul 4, 2022
the Oncogenic Potential of Salivary miRNA-93 and miRNA-412-3P in
Recruiting
- Oral Lichen Planus
- Oral Cancer
-
Cairo, Egypt
- +1 more
Jan 23, 2023
Varicose Veins Trial in London (Class II Compression Stockings (no specific device used))
Completed
- Varicose Veins
- Class II Compression Stockings (no specific device used)
-
London, United KingdomCharing Cross Hospital, Imperial College London
Aug 4, 2022
Diabetes Type 2 Trial in Seongnam (Dapagliflozin 10mg Tab, Lobeglitazone 0.5 mg, Dapagliflozin + Lobeglitazone)
Recruiting
- Diabetes Type 2
- Dapagliflozin 10mg Tab
- +2 more
-
Seongnam, Gyeonggi, Korea, Republic ofSeoul National University Bundang Hospital
Jun 14, 2023
NSCLC Trial in Worldwide (Atezolizumab, Tiragolumab, Placebo)
Active, not recruiting
- Non-small Cell Lung Cancer
- Atezolizumab
- +2 more
-
Tempe, Arizona
- +40 more
Nov 11, 2022
Home Air Radon Testing, Lung Cancer Trial (Public health infographic (AIM 3), Online health promotion intervention tailored by
Not yet recruiting
- Home Air Radon Testing
- Lung Cancer
- Public health infographic (AIM 3)
- +3 more
- (no location specified)
Apr 17, 2023
Eosinophilic Esophagitis Trial in Australia, Spain, United States (APT-1011, Placebo oral tablet)
Completed
- Eosinophilic Esophagitis
- APT-1011
- Placebo oral tablet
-
Anniston, Alabama
- +54 more
Nov 9, 2022
stRess and exeRcize on the Outcome After Chemo-Radiation
Not yet recruiting
- Glioblastoma (GBM)
- Smartwatch
- +2 more
-
Maastricht, Limburg, NetherlandsMaastricht Radiation Oncology (Maastro)
Jun 21, 2022